Related by context. All words. (Click for frequent words.) 63 Anti Tumor Activity 62 Hematologic Malignancies 62 Oral Fingolimod 61 Preclinical Study 61 See CLINICAL PHARMACOLOGY 61 Confocal Microscopy 61 Autoimmune Diseases 61 Anti Tumor 61 Randomized Clinical Trials 61 Heart Transplant Recipients 61 Laryngeal Cancer 61 Recombinant Protein 61 Breast Ultrasound 61 Autoimmune Disease 61 Bone Metastases 60 Anti CD# Antibody 60 Inflammatory Disease 60 Clinical Outcome 60 Antibody Discovery 60 Kinase Inhibitors 60 Antiviral Activity 60 Antitumor Activity 60 liners promos voicetracking 60 Image Guided 60 Phase Ib Clinical Trial 60 Novel Therapeutic 60 Novel Therapeutics 59 Kinase Inhibitor 59 Randomized Study 59 Shows Promise Against 59 Study Evaluating 59 Dendritic Cells 59 Hematology Molecular Pathology 59 Vaccine Adjuvants 59 Demonstrates Sustained 59 Vaccine Adjuvant 59 Mouse Models 59 HER2 Positive 59 RNAi Therapeutic 59 Prolongs Survival 59 Provectus Pharmaceuticals specializes 59 By TOMMY PRIDDY 59 Metabolic Disease 59 Therapeutic Antibody 59 Small Molecule 59 Initiates Clinical Trial 59 Diabetic Foot Ulcer 59 Soft Tissue Sarcoma 59 Biomarker Discovery 59 REMINDER ORLive Presents 59 Kidney Transplant Patients 59 Cardioxyl Pharmaceuticals 59 Nicotine Vaccine 59 Treatment Reduces 59 Lipid Metabolism 58 Cardiovascular Imaging 58 Pooled Analysis 58 M.D. Ph.D. 58 ST Segment Elevation 58 Advanced Renal Cell 58 Prenatal Diagnosis 58 DNA Methylation 58 HCV Protease Inhibitor 58 Presents Preclinical Data 58 Nuclear Receptors 58 Lung Cancer Trial 58 primary humoral immunodeficiency 58 Prolexys 58 Cardiotoxicity 58 Novel Inhibitor 58 Protein Expression 58 Implantable Device 58 Relapsed Refractory 58 Adjuvant Chemotherapy 58 Immune Cell 58 Gastric Cancer 58 Immunotherapeutic 58 Inflammatory Arthritis 58 pralatrexate injection folate analogue 58 Novel Oral 58 Hedgehog Pathway 58 Cardiovascular Magnetic Resonance 58 Anticancer Activity 58 Clinical Trial Results 58 Drug Eluting Coronary Stent 58 Molecular Diagnostic 58 Antibody Therapeutics 58 Recurrent Breast Cancer 58 Cardiac Arrhythmia 58 Hepatocellular Carcinoma 58 #:#-# [007] 58 Initiates Enrollment 58 Non Invasive Treatment 58 Autologous Stem Cell Transplantation 58 Neurotherapeutics 58 Mitochondrial Medicine 58 First Patient Treated 58 Hormone Refractory Prostate Cancer 58 Renal Cancer 58 Mitral Valve Repair 58 DANIEL WILLIAMS 58 MKC# MKC# PP 57 Marillion Pharmaceuticals 57 Epiphany Biosciences 57 ORLive Presents 57 Ceflatonin R 57 Preclinical Data 57 Adenoma 57 Molecular Diagnostic Test 57 Cancer Immunotherapy 57 Valvular Heart Disease 57 Meta Analysis 57 Cardiac Rhythm 57 Biological Therapy 57 Diagnostic Tests 57 Hemostasis 57 Cardiac Stem Cell 57 Patients Treated With 57 Gastrointestinal Cancers 57 Dose Escalation 57 AVI BioPharma Announces 57 Hematological Malignancies 57 ARRY # 57 Immunomedics Announces 57 TenFold Announces 57 Islet Transplantation 57 Antiviral Therapy 57 Tumor Response 57 Metastatic Melanoma 57 Radiopharmaceutical 57 Poster Presentation 57 Drug Prevents 57 Prospective Randomized 57 Cell Transplant 57 Parathyroid 57 Phase 2b Clinical Trial 57 Intracranial Aneurysms 57 Tyrosine Kinase Inhibitor 57 Alligator Bioscience AB 57 BiTE Antibody 57 Bone Marrow Transplants 57 Inflammatory Diseases 57 Preclinical Testing 57 FDA Approves Drug 57 Teva Provides Update 57 Heart Failure Therapy 57 Improves Outcomes 57 Cancer Stem Cells 57 Migraine Treatment 57 Treatment Approaches 57 Randomized Controlled Trials 57 Angiographic 57 Systemic Sclerosis 57 Genes Identified 56 Systemic Delivery 56 Kahalalide F 56 Neurodegenerative Disease 56 Meets Primary Endpoint 56 Immunogenicity 56 Renal Anemia 56 Randomized Double Blind 56 Endotoxin Activity Assay 56 Prospective Multicenter 56 Cervical Dysplasia 56 Oligonucleotide 56 Slows Progression 56 ActivX Biosciences 56 Intravascular 56 Relapsing Multiple Sclerosis 56 Novel Therapies 56 Stent Thrombosis 56 Preclinical Models 56 Valve Replacement 56 Gene Mutation 56 siRNA Delivery 56 Treatment Algorithm 56 Ovarian Cancer Patients 56 Autoimmunity 56 Minimally Invasive Treatment 56 Innate Immune 56 II Clinical Trial 56 Hospital Acquired Pneumonia 56 Completes Enrollment 56 Multicenter Randomized 56 Extracellular Matrix 56 Focused Ultrasound 56 Shows Efficacy 56 Anti Angiogenesis 56 Newly Diagnosed 56 Clinical Efficacy 56 Genetic Predisposition 56 Successfully Treated 56 Phase 2b Trial 56 Treatment Naive Patients 56 Male Contraceptive 56 Thyroid Hormone 56 Artery Disease 56 Biologics Manufacturing 56 RNAi Therapeutics 56 Antipsychotic Drug 56 Therapeutic Targets 56 Neoadjuvant Chemotherapy 56 Monoclonal 56 Myocardial Ischemia 56 Gene Linked 56 Less Invasive 56 J.P. Morgan Healthcare 56 Phase 2a Clinical Trial 56 Molecular Pathogenesis 56 Progenitor Cells 56 Clinical Trial Evaluating 56 Vascular Grafts 56 Ozarelix 56 Advanced Ovarian Cancer 56 Drug Shows Promise 56 Multicenter Phase 56 Hepatocellular 56 First Patient Enrolled 56 Female Urology 56 Patients Suffering 56 Digital Pathology 56 Statin Therapy 56 Osteoporosis Treatment 56 Neuroendocrine Tumors 56 Interventional Neuroradiology 56 Collaborators Present 56 Study Validates 56 Pediatric Rheumatology 56 Respiratory Virus 56 RNA Amplification 56 Drug Combo 56 Completes Patient Enrollment 56 Catheter Ablation 56 Treatment Resistant 56 Chronic Hepatitis C 56 Smooth Muscle 56 Pemphigus Vulgaris 56 Biologic Therapy 56 Therapeutic Efficacy 56 EnVivo Pharmaceuticals 56 Cancer Therapies 56 JAK2 Inhibitor 56 Present Preclinical Data 56 Oncologic 56 Clinical Outcomes 56 Acute Decompensated Heart Failure 56 Oral Presentations 56 Investigational Agent 56 Breast Tumor 55 Molecular Virology 55 Multicenter Study 55 Valvular 55 Metabolic Disorders 55 Iron Overload 55 ST Elevation Myocardial 55 Cognitive Problems 55 Maven Semantic 55 Coronary Revascularization 55 Circulatory Support 55 Advanced Prostate Cancer 55 FDA Okays 55 Cell Signalling 55 includes Dideco CarboMedics 55 Phase III Pivotal 55 Receives Orphan Drug 55 Antibody Engineering 55 Novel Mechanism 55 Preclinical Studies 55 EMD Biosciences Inc. 55 Renal Cell Carcinoma 55 Anticancer Agent 55 Treatment Experienced 55 Nanoemulsion 55 Lupus Drug 55 Improve Diagnosis 55 Novel Antibiotic 55 Total Knee Arthroplasty 55 Vaccine Trials 55 Advanced Melanoma 55 Chronic Lymphocytic Leukemia 55 Sapacitabine 55 Prognostic Value 55 Ichor Medical Systems 55 Viral Infections 55 Myelodysplastic Syndromes 55 Reports Preclinical Data 55 Diagnostic Tools 55 Hematopathology 55 Randomized Double blind 55 Peripheral Arterial 55 Survival Benefit 55 Acute Stroke 55 Guidelines Recommend 55 SIX RO ROG 55 Nucleic Acids 55 Genes Involved 55 Successfully Completes Phase 55 Receives Orphan Drug Designation 55 Cardiac Resynchronization Therapy 55 Pelvic Surgery 55 Pfizer Regenerative Medicine 55 Adjuvant Treatment 55 Neuroprotection 55 Patient Enrollment 55 Proves Effective 55 Antisense Drug 55 Hospitalized Patients 55 Hsp# Inhibitor 55 vitro pharmacology 55 Minimally Invasive Procedure 55 Integrative Neurosciences 55 Confirms Efficacy 55 Gene Silencing 55 Transdermal Patch 55 Files IND 55 writer GRN 55 Fungal Infections 55 Signal Transduction 55 Sipuleucel T 55 Carotid Stenting 55 Molecular Breast 55 AFREZZA TM 55 Agios Pharmaceuticals 55 Gynecological Cancers 55 Confirmatory Phase 55 Granted Orphan Drug 55 xCELLigence RTCA 55 Arch Neurol 55 Fibromyalgia Syndrome 55 Phase III Trial 55 Therapeutic Antibodies 55 Cytometry 55 Announces FDA Clearance 55 Translational Biology 55 Tibotec BVBA 55 Phase Ib II 55 Genetic Disorders 55 Prostate Biopsy 55 Hepatitis C Treatment 55 Complicated Skin 55 Vaccine Shows Promise 55 OSIsoft www.osisoft.com delivers 55 Monoclonal Antibody 55 Therapeutic Vaccines 55 RNA Therapeutics 55 Receives Milestone Payment 54 Genes Linked 54 Randomized Phase III 54 Pediatric Endocrinology 54 Attrius ™ PET 54 Glaucoma Treatment 54 Current Author Addresses 54 Lung Injury 54 Randomized Controlled 54 Uterine Fibroid Embolization 54 Vulnerable Plaque 54 Initiates Clinical 54 Treating Depression 54 Elderly Patients 54 NASDAQ CPHD 54 ASM Biodefense 54 Elagolix 54 IND Filing 54 Interventional Procedures 54 #:#-# [001] 54 RNA Interference 54 Survivorship Program 54 Hematologic Oncology 54 Demonstrates Positive 54 Hematologic 54 Hematological Cancers 54 Selects Allscripts 54 CT Angiography 54 Tumor Microenvironment 54 PET Scanner 54 Urinary Incontinence 54 Arno Therapeutics 54 Topline Results 54 Allergic Diseases 54 Transcatheter 54 Poster Presentations 54 Interventional Oncology 54 Phase 2a Trial 54 Severe Asthma 54 Angiogenic 54 AIR2 Trial 54 Treating Chronic 54 Cardiovascular Interventional 54 Genetic Testing 54 Long Term Efficacy 54 Investigational Compound 54 Protease Inhibitor 54 Advanced Colorectal Cancer 54 Regado Biosciences 54 NAVISTAR R 54 Pancreatic Adenocarcinoma 54 Endovascular Treatment 54 High Throughput Biology 54 Improves Survival 54 Tumor Biology 54 Subgroup Analysis 54 Phase III Clinical Trials 54 Breast Cancer Recurrence 54 endoluminal stent graft 54 FDA Approvals 54 Regenerative Cell 54 Urology Gynecology 54 Contrast Enhanced 54 Radiation Treatment 54 Investigational Treatment 54 Ischemic Stroke 54 Rheumatoid Arthritis Patients 54 Minimally Invasive Therapy 54 Patients Enrolled 54 Severe Sepsis 54 AGY Therapeutics 54 Phase IIa Clinical Trial 54 NABTT 54 ATS Simulus R 54 Dose Ranging 54 Minimally Invasive Spine Surgery 54 Intrinsic Imaging 54 Bioartificial Liver 54 Small Molecules 54 Anticoagulation 54 Phase 1b Clinical Trial 54 Phase IIb Clinical Trial 54 Solid Tumors 54 Bryan Cervical Disc 54 Fetal Medicine 54 Drug Candidate 54 Novel Treatments 54 Acute Ischemic Stroke 54 Malignancies 54 Perioperative Care 54 Endologix Powerlink System 54 Randomized Clinical Trial 54 Molecular Medicine Tri 54 Newly Diagnosed Multiple Myeloma 54 Oral Insulin 54 CyberKnife Radiosurgery 54 Shows Promising 54 Embolization 54 VisEn Medical 54 Daxor Corporation 54 Myocet 54 Diabetic Patients 54 Endothelial 54 Cell Signaling 54 Submits Biologics License Application 54 MEK Inhibitor 54 Protease Inhibitors 54 Estrogen Therapy 54 Retinal Degeneration 54 Gene Expression Profiling 54 Initiates Phase II 54 High Throughput Sequencing 54 Hedgehog Pathway Inhibitor 54 Ascenta Therapeutics 54 Solid Tumor 54 Chronic Heart Failure 54 Cardiac Electrophysiology 54 Vascular Targeting Agents 54 Stem Cell Transplants 54 Islet Transplant 54 Colorectal Adenomas 54 Brentuximab Vedotin SGN 54 Refractory Angina 54 Chemotherapeutic Agents 54 Bayer HealthCare Diagnostics 54 Cardiac Imaging 54 Regenerative Cells 54 Solid Malignancies 54 pharmacogenomic translational research 54 Venous Thromboembolism 54 Early Diagnosis 54 Advanced Pancreatic Cancer 54 Cardiometabolic 54 Inhaled Liposomal Ciprofloxacin 54 Retrovirus 54 Heart Failure Treatment 53 Cognitive Disorders 53 Investigator Initiated 53 Decision Biomarkers 53 Omacetaxine 53 Hernia Repair 53 Treatment Regimen 53 Biomarker Study 53 Immune Disease 53 Musculoskeletal Diseases 53 Bioprocess 53 Pharmacokinetic Study 53 Randomized Phase 53 Adjunctive Therapy 53 Contrast Agent 53 Combination REOLYSIN R 53 Initiates Phase III 53 Successfully Treats 53 AACR Meeting 53 Kidney Function 53 Neurochemistry 53 Stem Cell Transplant 53 Targeted Therapies 53 Safinamide 53 Pulmonary Arterial Hypertension 53 Surgery Performed 53 Improved Survival 53 Atopic Dermatitis 53 Pivotal Study 53 SABCS 53 Insulin Resistance 53 writer VGK 53 Genetic Screening 53 stent DES 53 Schizophrenia Treatment 53 Oral Presentation 53 Gynecol Oncol 53 Stent Placement 53 Blood Cancers 53 Acute Myocardial Infarction 53 Initiates Clinical Trials 53 Developmental Therapeutics 53 Allergy Cardiovascular 53 Teriflunomide 53 Guidelines Issued 53 Cancer Biomarkers 53 Ophthalmic Surgery 53 Clinical Proteomics 53 Immune Monitoring 53 Multidetector CT 53 Tumor Targeting 53 Neuroendocrine Tumor 53 Observational Study 53 Hepatobiliary 53 Improve Patient Outcomes 53 Phase III Clinical Trial 53 Immune Mediated 53 Breast Cancer Treatment 53 Patients Receiving 53 USGI Medical 53 Chronic Lymphocytic Leukemia CLL 53 Hematological 53 Postmenopausal Women 53 Roche LightCycler ® 53 Preclinical Development 53 Microvascular 53 Aurora Kinase 53 Late Breaker 53 Mesothelioma Treatment 53 Seasonal Influenza Vaccine 53 Prostate Cancer Patients 53 Genitourinary 53 Initiate Clinical Trial 53 Asthma Treatment 53 Orthopaedic Spine 53 Behavioral Biology 53 Bipolar Disorders 53 Rhinosinusitis 53 Gastrointestinal Oncology 53 Pancreas Cancer 53 Insulin Pen 53 Tuberculosis Vaccine 53 Protein Interactions 53 Metabolomic 53 Unresectable 53 Stem Cell Treatment 53 Gene Expression Analysis 53 Tissue Repair 53 Carotid 53 Liver Surgery 53 Metastatic Cancer 53 Stem Cell Differentiation 53 Bipolar Depression 53 Cholesterol Levels SPARCL 53 Biomarker 53 Embolic Protection 53 Advanced Heart Failure 53 Clinical Hematology 53 Trial Evaluating 53 Cardiac Catheterization 53 Ischemic 53 Preclinical Efficacy 53 Basic Biomedical Sciences 53 Protein Synthesis 53 Malignancy 53 Cancer Vaccine 53 Immunogenetics 53 Preterm Labor 53 Completes Dosing 53 Combination Therapy 53 Clinical Trial Data 53 Perfusion Index 53 Cytopathology 53 Integrative Neuroscience 53 Diagnostic Criteria 53 Neurogenic 53 Thoraxcenter Erasmus University 53 Experimental Hematology 53 Computed Tomographic 53 Transdermal Delivery 53 Peritoneal Dialysis 53 Eye Diseases 53 Catheterization Laboratory 53 Heart Failure Patients 53 Anti Infective 53 Novel Antibody 53 Functional Neurosurgery 53 NICE Recommends 53 C1 Inhibitor 53 Syndax Pharmaceuticals Inc. 53 Antithrombotic 53 Liver Cancer 53 Novel Vaccine 53 GlaxoSmithKline MedImmune 53 Antiplatelet Therapy 53 ERYtech 53 Study Evaluates 53 Cypher Sirolimus 53 Oximetry 52 Pediatrix Acquires 52 transcranial Doppler ultrasound 52 Antiangiogenic 52 Spinal Implant 52 Genetics Laboratory 52 Edimer Pharmaceuticals 52 Pediatric Neurology 52 Slow Progression 52 Immunotherapeutics 52 Ocular Diseases 52 ID NCT# 52 Hospital Universitari 52 Stereotactic 52 Patients Undergoing 52 Vascular Imaging 52 ICAAC IDSA 52 Investigational Drug 52 Acute Treatment 52 Cardiovascular Outcomes 52 Cell Differentiation 52 Surgical Mesh 52 Inherited Disease Research 52 J Neurosurg 52 JAK Inhibitor 52 Ribosomal 52 Nonalcoholic Steatohepatitis 52 Skin Grafts 52 Cardiothoracic Anesthesia 52 Platinum Chromium Coronary Stent 52 Hemodialysis Patients 52 Osteoarthritis Patients 52 number NCT# ClinicalTrials.gov 52 MR Angiography 52 KYTHERA Biopharmaceuticals Inc. 52 Heart Failure Clinic 52 Adjuvant Breast Cancer 52 Initiates Phase 2b 52 Tissue Engineered 52 Sentinel Lymph Node Biopsy 52 PET Imaging 52 Renal Artery 52 Cancer Therapeutic 52 Rheumatoid Arthritis Drug 52 Single Incision 52 Biopsy System 52 Oral Cladribine 52 Novel Small Molecule 52 Hormone Therapy 52 Aneurysm Repair 52 SpO2 pulse rate 52 Intra operative 52 Versus Placebo 52 Dosimetry 52 Immunobiology 52 Acute Heart Failure 52 Therapeutic Potential 52 TheraSphere R 52 Pain Medication 52 Novel Approaches 52 Hormone Replacement 52 Panacea Pharmaceuticals 52 Initiates Dosing 52 TearLab TM 52 UCSF Diabetes 52 Beerse Belgium 52 Male Infertility 52 Avila Therapeutics 52 Radiosurgery 52 Combination Treatment 52 #:#-# [024] 52 Clinical Trials Consortium 52 DermTech International 52 SILAC 52 UCSF Comprehensive Cancer 52 Awarded Qualifying Therapeutic 52 Metabolic Disorder 52 Cancer Immunotherapeutics 52 Patient Outcomes 52 Urogynecology 52 GenPath 52 Endocrinology Metabolism 52 Breast Brachytherapy 52 Doripenem 52 Malignant Melanoma 52 Scripps Genomic Medicine 52 Electrophysiology Mapping 52 Cardiac Transplant 52 Ophthotech 52 Cartilage Repair 52 Anticancer Drug 52 Hypercholesterolemia 52 Ion Channels 52 Psoriasis Drug 52 Cardiovascular Monitoring 52 albiglutide 52 Spinal Fusion 52 Gastroenterology Hepatology 52 Myoblast 52 Blood Pressure Monitoring 52 Wound Treatment 52 Treatment Outcome 52 Pink Sheets RHHBY 52 Migraine Drug 52 Bladder Cancer 52 radiofrequency RF ablation 52 Chiron Diagnostics 52 Alvine Pharmaceuticals 52 Author Affiliations 52 Pivotal Trials 52 Prostate Cancers 52 Individualized Therapy 52 Demonstrates Significant 52 Medical Research Katholic 52 Demonstrates Potent 52 Surgical Outcomes 52 Cell Lymphoma 52 Experimental Therapeutics Program 52 Pulmonary Critical Care 52 Genome Sequencing 52 Hepatitis C Virus 52 Cellular Therapies 52 Pediatric Imaging 52 Gets FDA Clearance 52 Developmental Genetics 52 Efficacy Trial 52 Vascular Ultrasound 52 Erectile Dysfunction Drug 52 Chronic Hepatitis B 52 access graft VAG 52 Osteoarthritis Pain 52 Molecular Evolution 52 Bazedoxifene 52 Kidney Transplantation 52 Neural Stem Cells 52 Anti Clotting Drug 52 Outcome Sciences 52 Drug Metabolism 52 #p# [003] 52 Phytomedics Inc. 52 Prostate Cancer Vaccine 52 Reperfusion Injury 52 FDA Clears 52 stage hypoxia activated 51 Blood Pressure Drug 51 Patients Treated 51 NCI Comprehensive Cancer 51 Carotid Stent 51 Integra LifeSciences Announces 51 Percutaneous Transluminal Coronary Angioplasty 51 Therapeutics Roundtable 51 Resection 51 Multiple Myeloma Patients 51 Epilepsy Drug 51 Imaging Technique 51 Cutaneous Oncology 51 Clinical Evaluation 51 Clinical Guideline 51 By Misha Berson 51 Metabolic Diseases 51 Tissue Engineering 51 Exploratory Clinical 51 Molecular Spectroscopy 51 Hainan Helpson Medical 51 Disease Progression 51 descending thoracic 51 Neoplasia 51 Protein Therapeutics 51 includes introducers guidewires 51 Neuromuscular Research 51 Ocera Therapeutics 51 Breast Biopsy 51 Balloon Catheters 51 Cardiac Pacing 51 Anticalin R 51 Lung Cancer Drug 51 Fragment Library 51 Molecular Basis 51 Diabetic Nephropathy 51 TargeGen 51 Anticoagulant 51 Breast Cancer Survival 51 Genetic Epidemiology 51 Chronic Inflammation 51 Infectious Disease Testing 51 www.osisoft.com 51 Ortho Biotech Oncology 51 Gene Expression 51 Recombinant Human 51 Ocular Pharmacology 51 Prostate Cancer Treatment 51 Breast Cancer Metastasis 51 Enrolling Patients 51 ISPOR 51 Asthma COPD 51 Protein Interaction 51 Trauma Fixation 51 Endurant 51 DeBakey Heart 51 Surgical Pathology 51 Risk Stratification 51 Synthetic Peptide 51 Resistant Hypertension 51 Metabolomics 51 Biotherapeutics 51 Spinal Disc 51 DNA Sequencer 51 CABG Surgery 51 Glycemia 51 Quark Biotech Inc. 51 Endovascular Repair 51 Shailaja Neelakantan 51 Phase IIb Trial 51 Neuropharmacology 51 Group RTOG 51 Chronic Myeloid Leukemia 51 Clinical Validation 51 Lung Cancer Patients 51 Drug Resistant 51 MelaFind R 51 Orthopedic Implant 51 Cutaneous T 51 Chronic Care 51 Presents Positive 51 Archexin 51 Pediatric Urology 51 aneurysms AAA 51 Bone Marrow Transplantation 51 KAI Pharmaceuticals Inc. 51 Epidemiological Studies Unit 51 Retinal Diseases 51 Virtual Colonoscopy 51 By DANNY O'NEIL 51 Oncogene 51 Chronogen 51 Myelofibrosis 51 Volcano Therapeutics 51 Inflammatory Bowel Diseases 51 OMRIX Biopharmaceuticals Inc. 51 Personalised Medicine 51 Talent Abdominal 51 Cardiovascular Metabolic 51 Vaccine Protects Against 51 CLIA Lab 51 Drug Eluting 51 Vascular Medicine 51 Kidney Transplants 51 Gout Drug 51 Resolvyx Pharmaceuticals 51 Memgen 51 Drug Repositioning 51 Receives Marketing Authorization 51 iPS Cells 51 Improve Survival 51 Darbepoetin Alfa 51 Pivotal Phase II 51 Nanoscale Systems 51 Extends Collaboration 51 Oxford Genome Sciences 51 Clinical Therapeutics 51 Romidepsin 51 Molecular Biomarkers 51 Genetic Tests 51 Pulse Oximetry 51 Renal Failure 51 Clinically Significant 51 Phase 2b Study 51 Marrow Transplant 51 Xceed Molecular 51 Neuro oncology 51 Transcatheter Valve 51 GORE TAG Device 51 Respiratory Viruses 51 Immunodeficiency 51 Pain Therapy 51 Aortic Valve Replacement 51 PerkinElmer Acquires 51 Neonatal Care 51 Sidney Kimmel Cancer 51 products BioTime develops 51 UEGW 51 Cancer Vaccines 51 Myocardial Infarction 51 #:#-# [033] 51 Osteoporosis Drug 51 Functional Brain 51 Pharmacogenomic 51 Brain Imaging 51 Male Fertility 51 Pirfenidone 51 NCI Cancer 51 Pivotal Phase 51 Molecular Profiling 51 Dietary Intervention 51 Biliary System 51 Milestone Payment 51 Oxidative Stress 51 Pharm Olam International 51 Etiology 51 Lumbar Interbody Fusion 51 Neurome 51 Genetic Diseases 51 Dynamic Spine Stabilization 51 Angiogenesis 51 Pathology Informatics 51 NHGRI Division 51 Virtual Microscopy 51 Dual Antiplatelet Therapy 51 Clinical Trial Enrollment 51 Previously Treated 51 Interferon Alpha 51 Pathogenesis 51 Functional Genomics 51 Interventional Pain Management 51 Avian Flu Vaccine 51 Recurrent Prostate Cancer 50 RT PCR assays 50 hepatoma 50 AviaraDx 50 Surgeons Perform 50 Phase III Trials 50 Personalized Immunotherapy 50 Arterial Disease 50 Edwards SAPIEN 50 Neurodegenerative 50 Patient Recruitment 50 Perinatal Care 50 Tissue Regeneration 50 Drug Formulation 50 PharmD MPH 50 Infected Patients 50 Immunology Rheumatology 50 Left Atrial Appendage 50 Translational Science Award 50 Adjuvanted 50 Therapeutic Approaches 50 Immunodiagnostics 50 Small Bowel 50 IDEV Technologies 50 please visit www.brighamandwomens.org 50 Anticancer Agents 50 urology oncology 50 Non Invasive 50 Cerionx 50 Acute Coronary Syndromes 50 Cardiac Marker 50 Antimicrobial Coating 50 Monoclonal Antibodies 50 By JERRY BREWER 50 Diabetes Endocrinology 50 Correlogic Systems Inc. 50 Drug Eluting Stent 50 Combo Therapy 50 Ischemia 50 Pandemic Influenza Vaccines 50 Postmenopausal Osteoporosis 50 BioProcessors 50 Acute Coronary Syndromes ACS 50 Gastrointestinal Disorders 50 Pivotal Clinical Trial 50 Heart Transplantation 50 Pervasis 50 Caris MPI 50 AMPLATZER R 50 Mirus Bio Corporation 50 #:# -# [003] 50 Bacchus Vascular 50 Imaging Informatics 50 Post Operative 50 Glucose Monitoring 50 Immunosuppressant 50 Cytology 50 Hemorrhagic Stroke 50 NDA Submission 50 ISTODAX ® 50 By ADAM LIPTAK 50 Spectral Imaging 50 Ph.D. D.Sc. 50 Platelet Inhibition 50 Psychiatric Disorders 50 Hemodynamics